| Record Information |
| Version |
3.5 |
| Creation Date |
2007-04-12 14:13:16 -0600 |
| Update Date |
2013-02-08 17:14:27 -0700 |
| HMDB ID |
HMDB06005 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Indolylacryloylglycine |
| Description |
Indolylacryloylglycine (IAG) is a compound that is derived, in the same way as many other indole compounds, from tryptophan or indole compounds in the diet. It is likely a product of gut metabolism although the exact source is still unclear. IAG is elevated in the urine of autistic children with gastrointestinal disturbances. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- IAG
- Indole-3-acryloyl-glycine
- Indoleacrylic glycine
- Indolyl acryloylglycine
- N-(3-(1-Indol-3-yl)-1-oxo-2-propenyl)glycine
|
| Chemical Formula |
C13H12N2O3 |
| Average Molecular Weight |
244.246 |
| Monoisotopic Molecular Weight |
244.08479226 |
| IUPAC Name |
2-[(2E)-3-(1H-indol-3-yl)prop-2-enamido]acetic acid |
| Traditional IUPAC Name |
[(2E)-3-(1H-indol-3-yl)prop-2-enamido]acetic acid |
| CAS Registry Number |
3475-68-1 |
| SMILES |
OC(=O)CNC(=O)\C=C\C1=CNC2=CC=CC=C12 |
| InChI Identifier |
InChI=1S/C13H12N2O3/c16-12(15-8-13(17)18)6-5-9-7-14-11-4-2-1-3-10(9)11/h1-7,14H,8H2,(H,15,16)(H,17,18)/b6-5+ |
| InChI Key |
DUIFVCFSAWHIOD-AATRIKPKSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Amino Acids, Peptides, and Analogues |
| Class |
Amino Acids and Derivatives |
| Sub Class |
Alpha Amino Acids and Derivatives |
| Other Descriptors |
- Alpha Amino Acids and Derivatives
- Aromatic Heteropolycyclic Compounds
|
| Substituents |
- Carboxamide Group
- Carboxylic Acid
- Enone
- Indole
- Pyrrole
- Secondary Carboxylic Acid Amide
|
| Direct Parent |
Acyl Glycines |
| Ontology |
| Status |
Expected and Not Quantified |
| Origin |
|
| Biofunction |
Not Available |
| Application |
Not Available |
| Cellular locations |
Not Available |
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
Not Available |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
Not Available
|
| Biological Properties |
| Cellular Locations |
Not Available
|
| Biofluid Locations |
Not Available
|
| Tissue Location |
Not Available
|
| Pathways |
Not Available
|
| Normal Concentrations |
|
Not Available |
| Abnormal Concentrations |
|
Not Available |
| Associated Disorders and Diseases |
| Disease References |
None |
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB023799 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
4521424  |
| KEGG Compound ID |
Not Available |
| BioCyc ID |
Not Available |
| BiGG ID |
Not Available |
| Wikipedia Link |
Not Available |
| NuGOwiki Link |
HMDB06005  |
| Metagene Link |
HMDB06005  |
| METLIN ID |
Not Available |
| PubChem Compound |
5370648  |
| PDB ID |
Not Available |
| ChEBI ID |
Not Available |
| References |
| Synthesis Reference |
Not Available |
| Material Safety Data Sheet (MSDS) |
Not Available
|
| General References |
- Bull G, Shattock P, Whiteley P, Anderson R, Groundwater PW, Lough JW, Lees G: Indolyl-3-acryloylglycine (IAG) is a putative diagnostic urinary marker for autism spectrum disorders. Med Sci Monit. 2003 Oct;9(10):CR422-5.
Pubmed: 14523330
- Wright B, Brzozowski AM, Calvert E, Farnworth H, Goodall DM, Holbrook I, Imrie G, Jordan J, Kelly A, Miles J, Smith R, Town J: Is the presence of urinary indolyl-3-acryloylglycine associated with autism spectrum disorder? Dev Med Child Neurol. 2005 Mar;47(3):190-2.
Pubmed: 15739724
- Anderson RJ, Bendell DJ, Garnett I, Groundwater PW, Lough WJ, Mills MJ, Savery D, Shattock PE: Identification of indolyl-3-acryloylglycine in the urine of people with autism. J Pharm Pharmacol. 2002 Feb;54(2):295-8.
Pubmed: 11858215
|